Pelin Tanyeri
Research Subjects
Research Interests
Pelin Tanyeri has a total of 380 co-authors. Here are the top co-authors by number of shared publications:
- Oguz Mutlu
Kocaeli University, Turkey
10 shared publications Oguz Mutlu
Kocaeli University, Faculty of Medicine, Department of Pharmacology, Umuttepe Street, Number: 515, 41001, İzmit, Kocaeli-Turkey
8 shared publicationsBekir Faruk Erden
7 shared publicationsMehmet Emin Buyukokuroglu
Sakarya University, Faculty of Medicine, Department of Pharmacology, Konuralp Street, Number: 81, 54290, Adapazarı, Sakarya-Turkey
7 shared publicationsGüner Ulak
6 shared publications- Mehmet Emin Büyükokuroğlu
SAKARYA ÜNİVERSİTESİ, TIP FAKÜLTESİ
6 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 11 (3) , 272-278
Investigation of the Effect of Phosphodiesterase Type 9 Inhibitor PF-04447943 on Spatial Memory in Mice Using the Radial Arm Maze Test
Objective: Phosphodiesterase-9 (PDE9) inhibitors have attracted interest for improving cognitive function by increasing intracellular cGMP, an important mediator of learning and memory. The nitric oxide (NO)/cGMP pathway plays a key role in synaptic plasticity and hippocampal long-term potentiation (LTP), while inhibition of neuronal nitric oxide synthase (nNOS) impairs cognition. This study evaluated the effects of the PDE9 inhibitor PF-04447943 on spatial memory in mice and its interaction with nNOS inhibition induced by 7-nitroindazole (7-NI).Materials and Methods: Fifty male BALB/c mice (7–8 weeks old, 20–30 g) were randomly divided into five groups (n = 10 per group): control, PF-04447943 (1 and 3 mg/kg), 7-Nitroindazole (7-NI; 5 mg/kg), and a combination treatment group (5 mg/kg 7NI and 3 mg/kg PF-04447943). Drugs were administered intraperitoneally (i.p.). The radial arm maze test was used to measure spatial memory by recording arm reentries (errors) and task completion time (latency).Results: PF-04447943 (1 and 3 mg/kg, i.p.) significantly decreased the number of errors and latency at 3 mg/kg. The nNOS inhibitor 7-NI (5 mg/kg) significantly increased both values. The combined treatment group made notably fewer mistakes and had significantly reduced latency than the 7-NI group, yet their performance was not completely restored to control levels.Conclusions: Inhibiting PDE9 may enhance spatial memory and partially alleviate cognitive impairment associated with the NO pathway; however, intact NO signalling seems essential for complete cognitive recovery.
- 15 September 2026
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 11 (3) , 272-278
Open AccessInvestigation of the Effect of Phosphodiesterase Type 9 Inhibitor PF-04447943 on Spatial Memory in Mice Using the Radial Arm Maze Test
Objective: Phosphodiesterase-9 (PDE9) inhibitors have attracted interest for improving cognitive function by increasing intracellular cGMP, an important mediator of learning and memory. The nitric oxide (NO)/cGMP pathway plays a key role in synaptic plasticity and hippocampal long-term potentiation (LTP), while inhibition of neuronal nitric oxide synthase (nNOS) impairs cognition. This study evaluated the effects of the PDE9 inhibitor PF-04447943 on spatial memory in mice and its interaction with nNOS inhibition induced by 7-nitroindazole (7-NI).Materials and Methods: Fifty male BALB/c mice (7–8 weeks old, 20–30 g) were randomly divided into five groups (n = 10 per group): control, PF-04447943 (1 and 3 mg/kg), 7-Nitroindazole (7-NI; 5 mg/kg), and a combination treatment group (5 mg/kg 7NI and 3 mg/kg PF-04447943). Drugs were administered intraperitoneally (i.p.). The radial arm maze test was used to measure spatial memory by recording arm reentries (errors) and task completion time (latency).Results: PF-04447943 (1 and 3 mg/kg, i.p.) significantly decreased the number of errors and latency at 3 mg/kg. The nNOS inhibitor 7-NI (5 mg/kg) significantly increased both values. The combined treatment group made notably fewer mistakes and had significantly reduced latency than the 7-NI group, yet their performance was not completely restored to control levels.Conclusions: Inhibiting PDE9 may enhance spatial memory and partially alleviate cognitive impairment associated with the NO pathway; however, intact NO signalling seems essential for complete cognitive recovery.
- Open Access
- 18 December 2023
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 8 (4) , 525-532
Neurochemical Effects of the Adipokinetic Hormone/Red Pigment Concentrating Hormone Family of Peptides in MK-801-Induced Schizophrenia Rat Model
Objective: Adipokinetic hormone (AKH) plays a role in sugar and lipid metabolism in insects. Previous studies of AKH showed memory improvements in a schizophrenia rat model that displayed memory impairment and reduced depression in a rat olfactory bulbectomy model. In this study, we investigated the effects of the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family of peptides on brain neurotransmitter levels and brain neurochemistry in a schizophrenia rat model. Materials and Methods: We administered AKH/RPCH peptides for 4 days sub-chronically, both in naive rats and also in the MK-801-induced schizophrenia rat model. Liquid chromatography-mass spectrometry apparatus was used for targeted and untargeted analysis of rat neurochemistry. Results: Increased brain glutamate levels characteristic of MK-801 peptide-treated rats were significantly reduced by AKH. Furthermore, AKH also increased brain dopamine levels in both naive and MK-801 rats. Metabolomic studies have shown that AKH affects lipid and glutamate metabolism, while hypertrehalosaemic hormone plays a role in sugar metabolism and inflammation. Conclusion: According to our results, AKH might affect dopaminergic and glutamatergic systems and reverse the effects of MK-801, possibly affecting NMDA receptors.
- 18 December 2023
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 8 (4) , 525-532
Open AccessNeurochemical Effects of the Adipokinetic Hormone/Red Pigment Concentrating Hormone Family of Peptides in MK-801-Induced Schizophrenia Rat Model
Objective: Adipokinetic hormone (AKH) plays a role in sugar and lipid metabolism in insects. Previous studies of AKH showed memory improvements in a schizophrenia rat model that displayed memory impairment and reduced depression in a rat olfactory bulbectomy model. In this study, we investigated the effects of the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family of peptides on brain neurotransmitter levels and brain neurochemistry in a schizophrenia rat model. Materials and Methods: We administered AKH/RPCH peptides for 4 days sub-chronically, both in naive rats and also in the MK-801-induced schizophrenia rat model. Liquid chromatography-mass spectrometry apparatus was used for targeted and untargeted analysis of rat neurochemistry. Results: Increased brain glutamate levels characteristic of MK-801 peptide-treated rats were significantly reduced by AKH. Furthermore, AKH also increased brain dopamine levels in both naive and MK-801 rats. Metabolomic studies have shown that AKH affects lipid and glutamate metabolism, while hypertrehalosaemic hormone plays a role in sugar metabolism and inflammation. Conclusion: According to our results, AKH might affect dopaminergic and glutamatergic systems and reverse the effects of MK-801, possibly affecting NMDA receptors.
- Open Access
- 11 August 2023
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Piroglutamil Peptidlerin Farelerde Skopolaminle Oluşturulmuş Öğrenme-Bellek Bozukluğu Üzerine Etkisi
Amaç: Önceki çalışmalarımızda adipokinetik hormonun (AKH) farelerde antidepresan, anksiyolitik, analjezik etkilerini, nörotrofik faktörleri ve nörojenezi artırdığını gösterdik. Önceki çalışmamızda, AKH’nun sıçanlara intraperitoneal uygulanmasından sonra diğer çalışmalarla desteklendiği şekilde piroglutamil peptidleri içeren AKH metabolitlerinin kan-beyin bariyerini geçtiğini hipotez ettik. Gereç ve Yöntemler: Bu çalışmada, iki piroglutamil peptidin öğrenme-bellek üzerine etkisini modifiye yükseltilmiş artı labirent testinde (mYAL) ve pasif sakınma testinde hem naif farelerde hem de skopolaminle indüklenen bellek bozukluğu üzerine etkisini incelemeyi amaçladık. Skopolamin (1 mg/kg) ile piroglutamil peptid olarak piroglutamik asid-valin (pGlu-Val; 10 ve 20 mg/kg), piroglutamik asid-lösin (pGlu-Leu; 10 ve 20 mg/kg) kullandık. Bulgular: mYAL testinde dipeptidlerin naif farelerde geçiş süresi-2 üzerine anlamlı etkisi yoktu. Skopolamin kısmi olarak ikinci denemede geçiş süresi-2’yi artırırken, bu etki pGlu-Leu (10 ve 20 mg/kg; p
- 11 August 2023
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Open AccessPiroglutamil Peptidlerin Farelerde Skopolaminle Oluşturulmuş Öğrenme-Bellek Bozukluğu Üzerine Etkisi
Amaç: Önceki çalışmalarımızda adipokinetik hormonun (AKH) farelerde antidepresan, anksiyolitik, analjezik etkilerini, nörotrofik faktörleri ve nörojenezi artırdığını gösterdik. Önceki çalışmamızda, AKH’nun sıçanlara intraperitoneal uygulanmasından sonra diğer çalışmalarla desteklendiği şekilde piroglutamil peptidleri içeren AKH metabolitlerinin kan-beyin bariyerini geçtiğini hipotez ettik. Gereç ve Yöntemler: Bu çalışmada, iki piroglutamil peptidin öğrenme-bellek üzerine etkisini modifiye yükseltilmiş artı labirent testinde (mYAL) ve pasif sakınma testinde hem naif farelerde hem de skopolaminle indüklenen bellek bozukluğu üzerine etkisini incelemeyi amaçladık. Skopolamin (1 mg/kg) ile piroglutamil peptid olarak piroglutamik asid-valin (pGlu-Val; 10 ve 20 mg/kg), piroglutamik asid-lösin (pGlu-Leu; 10 ve 20 mg/kg) kullandık. Bulgular: mYAL testinde dipeptidlerin naif farelerde geçiş süresi-2 üzerine anlamlı etkisi yoktu. Skopolamin kısmi olarak ikinci denemede geçiş süresi-2’yi artırırken, bu etki pGlu-Leu (10 ve 20 mg/kg; p
- Open Access
- 1 March 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (1) , 40-46
Chronic Effects of Loxapine, Iloperidone, Paliperidone on Mice Isolated Vas Deferens Contractility
Objective: Erectile dysfunction is a usual side effect of antipsychotic medications; this causes patients to avoid using drugs. The aim of this study to investigate the effects of iloperidone, paliperidone and loxapine on serotonin (5-HT), noradrenaline (NA), adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in mice.Materials and Methods: The mice were randomly divided into experimental groups and treated by ip injection of drugs for 21 days. After the treatment, the effects of drugs were investigated on 5-HT, ATP, NA and KCl-induced contractile responses in the epididymal and prostatic portions of mice vas deferens strips. Results: 5-HT-induced contractile responses were significantly increased while ATP-induced contractile responses were significantly decreased in the both portions of the vas deferens obtained from the iloperidone, paliperidone and loxapine-treated groups. However, these drugs had no significant effect on NA- and KCl-induced contractions of mice vas deferens. Conclusion: These results showed that serotonin and ATP-induced contractions of vas deferens were affected by the chronic treatments of iloperidone, paliperidone, and loxapine. In mice chronically treated with these drugs, serotonergic and purinergic receptors may contribute to changes in vas deferens contractions that cause erectile dysfunction.
- 1 March 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (1) , 40-46
Open AccessChronic Effects of Loxapine, Iloperidone, Paliperidone on Mice Isolated Vas Deferens Contractility
Objective: Erectile dysfunction is a usual side effect of antipsychotic medications; this causes patients to avoid using drugs. The aim of this study to investigate the effects of iloperidone, paliperidone and loxapine on serotonin (5-HT), noradrenaline (NA), adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in mice.Materials and Methods: The mice were randomly divided into experimental groups and treated by ip injection of drugs for 21 days. After the treatment, the effects of drugs were investigated on 5-HT, ATP, NA and KCl-induced contractile responses in the epididymal and prostatic portions of mice vas deferens strips. Results: 5-HT-induced contractile responses were significantly increased while ATP-induced contractile responses were significantly decreased in the both portions of the vas deferens obtained from the iloperidone, paliperidone and loxapine-treated groups. However, these drugs had no significant effect on NA- and KCl-induced contractions of mice vas deferens. Conclusion: These results showed that serotonin and ATP-induced contractions of vas deferens were affected by the chronic treatments of iloperidone, paliperidone, and loxapine. In mice chronically treated with these drugs, serotonergic and purinergic receptors may contribute to changes in vas deferens contractions that cause erectile dysfunction.
- Open Access
- 1 March 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (1) , 106-111
Haloperidol, Olanzapin, Risperidon ve Klozapinin Organ Banyosu Sistemi Kullanılarak Fare Detrusor Kası Üzerine Etkileri
Objective: The bladder normally shows no contractility or activity during the filling phase. In the overactive urinary bladder, spontaneous contractions and detrusor instability are seen in the filling phase and urinary incontinence occurs. This study aims to demonstrate the effects of first-generation antipsychotic haloperidol and second-generation antipsychotics olanzapine, risperidone, and clozapine on mice isolated bladder using the organ bath system. Materials and Methods: 63 male inbred mice were divided as saline, haloperidol 0.125 mg/kg, haloperidol 0.25 mg/kg, olanzapine 1 mg/kg, olanzapine 2 mg/kg, risperidone 0.25 mg/kg, risperidone 0.5 mg/kg, clozapine 1.25 mg/kg and clozapine 2.5 mg/kg groups. Mice were treated with drugs for 21 days. Then, the effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips. Results: We showed that carbachol-induced contractions relaxed by isoproterenol and papaverine in mice detrusor strips obtained from olanzapine, risperidone, and clozapine treated groups. There were no significant differences in KCl-induced contractile responses among the groups.Conclusion: Olanzapine, risperidone, and clozapine increased the isoproterenol-induced relaxations of the detrusor muscle that increased the bladder capacity. These drugs might be clinically useful for the treatment of overactive urinary bladder in patients that should use antipsychotic drugs.
- 1 March 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (1) , 106-111
Open AccessHaloperidol, Olanzapin, Risperidon ve Klozapinin Organ Banyosu Sistemi Kullanılarak Fare Detrusor Kası Üzerine Etkileri
Objective: The bladder normally shows no contractility or activity during the filling phase. In the overactive urinary bladder, spontaneous contractions and detrusor instability are seen in the filling phase and urinary incontinence occurs. This study aims to demonstrate the effects of first-generation antipsychotic haloperidol and second-generation antipsychotics olanzapine, risperidone, and clozapine on mice isolated bladder using the organ bath system. Materials and Methods: 63 male inbred mice were divided as saline, haloperidol 0.125 mg/kg, haloperidol 0.25 mg/kg, olanzapine 1 mg/kg, olanzapine 2 mg/kg, risperidone 0.25 mg/kg, risperidone 0.5 mg/kg, clozapine 1.25 mg/kg and clozapine 2.5 mg/kg groups. Mice were treated with drugs for 21 days. Then, the effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips. Results: We showed that carbachol-induced contractions relaxed by isoproterenol and papaverine in mice detrusor strips obtained from olanzapine, risperidone, and clozapine treated groups. There were no significant differences in KCl-induced contractile responses among the groups.Conclusion: Olanzapine, risperidone, and clozapine increased the isoproterenol-induced relaxations of the detrusor muscle that increased the bladder capacity. These drugs might be clinically useful for the treatment of overactive urinary bladder in patients that should use antipsychotic drugs.
- Open Access
- 21 February 2022
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
The Effects of Oxybutynin on Learning and Memory Functions In Passive Avoidance and Morris Water Maze Tests In Mice
Objective: Overactive bladder (OAB) constitutes the majority of childhood incontinence causes. Oxybutynin is an antimuscarinic agent frequently used for children in the treatment of OAB. This study aimed to investigate the effects of an antimuscarinic drug oxybutynin on learning and memory. Materials and Methods: We assessed the effects of oxybutynin on learning and memory functions using the Passive Avoidance (PA) and the Morris Water Maze (MWM) Test in mice. Results: Oxybutynin treatment (1 mg/kg, 2 mg/kg, and 4 mg/kg) did not show a significant difference in the retention time on the second day compared to the control and oxybutynin (4 mg/kg) significantly prolonged the retention time in scopolamine-treated mice. In the MWM Test, oxybutynin (1 mg/kg, 2 mg/kg, and 4 mg/kg) has no effect on the time spent in the target quadrant. Scopolamine (0.6 mg/kg) alone significantly reduced time spent in the target quadrant, but oxybutynin (4 mg/kg) significantly prolonged time spent in the target quadrant in scopolamine-treated mice. Also, scopolamine significantly increased the mean distance to the escape platform, while oxybutynin (4 mg/kg) significantly decreased the mean distance to the escape platform in scopolamine-treated mice. Conclusion: In our study, oxybutynin did not affect learning and memory, but it plays a role ameliorating the learning and memory deficits. The results of this study show that the use of oxybutynin in patients with OAB does not affect learning and memory.
- 21 February 2022
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Open AccessThe Effects of Oxybutynin on Learning and Memory Functions In Passive Avoidance and Morris Water Maze Tests In Mice
Objective: Overactive bladder (OAB) constitutes the majority of childhood incontinence causes. Oxybutynin is an antimuscarinic agent frequently used for children in the treatment of OAB. This study aimed to investigate the effects of an antimuscarinic drug oxybutynin on learning and memory. Materials and Methods: We assessed the effects of oxybutynin on learning and memory functions using the Passive Avoidance (PA) and the Morris Water Maze (MWM) Test in mice. Results: Oxybutynin treatment (1 mg/kg, 2 mg/kg, and 4 mg/kg) did not show a significant difference in the retention time on the second day compared to the control and oxybutynin (4 mg/kg) significantly prolonged the retention time in scopolamine-treated mice. In the MWM Test, oxybutynin (1 mg/kg, 2 mg/kg, and 4 mg/kg) has no effect on the time spent in the target quadrant. Scopolamine (0.6 mg/kg) alone significantly reduced time spent in the target quadrant, but oxybutynin (4 mg/kg) significantly prolonged time spent in the target quadrant in scopolamine-treated mice. Also, scopolamine significantly increased the mean distance to the escape platform, while oxybutynin (4 mg/kg) significantly decreased the mean distance to the escape platform in scopolamine-treated mice. Conclusion: In our study, oxybutynin did not affect learning and memory, but it plays a role ameliorating the learning and memory deficits. The results of this study show that the use of oxybutynin in patients with OAB does not affect learning and memory.
- 28 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 3633-3647
Effects of Tolterodine on Depression, Anxiety, Learning and Memory in Mice
Background: Overactive bladder (OAB) is characterized by urinary symptoms such as frequent urination, urgency, urinary incontinence, and nocturia. Tolterodine is a drug specially developed for the treatment of overactive bladder. The aim of present study is to evaluate the effects of tolterodine on depression, anxiety, learning and memory to understand if tolterodine may be effective in OAB caused mood and cognitive disorders. Methodology: Study Design: All the drugs were given intraperitoneally (i.p.), 30 min before the experiment. Here, we investigated the effects of tolterodine (0.3, 1, 3 mg/kg) on depression, anxiety, learning and memory by using forced swimming test, elevated plus maze test, passive avoidance, and Morris water maze, respectively in mice. Locomotor activity was evaluated by open field test. Place and Duration of Study: Department of Pharmacology and Department of Urology, Sakarya University, Animal Research Center, between August 2019 and September 2020. Results: All doses of tolterodine dose-dependently reduced immobility time, compared to saline group. Tolterodine (1, 3 mg/kg) prolonged the time spent in open arms compared to saline group. Tolterodine (3 mg/kg) significantly increased the number of entries into the open arms. Tolterodine had no effect on learning and memory performance of normal mice; however, tolterodine (3 mg/kg) significantly ameliorated learning and memory disruption induced by scopolamine. Conclusion: Our results demonstrate that tolterodine prevented experimentally induced depression and anxiety, improved memory and learning of naive animals, and reversed memory and learning impairment with scopolamine. Further preclinical and clinical studies with tolterodine should be done to support all these hypothesis and patients with OAB who need antidepressant and anxiolytic therapy may be treated with single drug instead of more than one drug in the future.
- 28 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 3633-3647
Effects of Tolterodine on Depression, Anxiety, Learning and Memory in Mice
Background: Overactive bladder (OAB) is characterized by urinary symptoms such as frequent urination, urgency, urinary incontinence, and nocturia. Tolterodine is a drug specially developed for the treatment of overactive bladder. The aim of present study is to evaluate the effects of tolterodine on depression, anxiety, learning and memory to understand if tolterodine may be effective in OAB caused mood and cognitive disorders. Methodology: Study Design: All the drugs were given intraperitoneally (i.p.), 30 min before the experiment. Here, we investigated the effects of tolterodine (0.3, 1, 3 mg/kg) on depression, anxiety, learning and memory by using forced swimming test, elevated plus maze test, passive avoidance, and Morris water maze, respectively in mice. Locomotor activity was evaluated by open field test. Place and Duration of Study: Department of Pharmacology and Department of Urology, Sakarya University, Animal Research Center, between August 2019 and September 2020. Results: All doses of tolterodine dose-dependently reduced immobility time, compared to saline group. Tolterodine (1, 3 mg/kg) prolonged the time spent in open arms compared to saline group. Tolterodine (3 mg/kg) significantly increased the number of entries into the open arms. Tolterodine had no effect on learning and memory performance of normal mice; however, tolterodine (3 mg/kg) significantly ameliorated learning and memory disruption induced by scopolamine. Conclusion: Our results demonstrate that tolterodine prevented experimentally induced depression and anxiety, improved memory and learning of naive animals, and reversed memory and learning impairment with scopolamine. Further preclinical and clinical studies with tolterodine should be done to support all these hypothesis and patients with OAB who need antidepressant and anxiolytic therapy may be treated with single drug instead of more than one drug in the future.
- 15 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 78-87
Effects of Terazosin, Silodosin and Alfuzosin on Depression and Anxiety in Mice
Aims: Benign prostatic hyperplasia (BPH) is common urological disease, is characterized by lower urinary tract syndrome, usually associated with sexual dysfunctions. The aim of present study is to investigate the effects of terazosin, silodosin and alfuzosin which are the main treatment options for BPH on depression and anxiety to understand whether these drugs may be effective in BPH caused mood disorders. Study Design: All the drugs were given intraperitoneally (i.p.) in a volume of 0.1 ml per 10 g body weight of mice. Drugs were given 30 min before the experiment. We investigated the effects of terazosin, silodosin and alfuzosin on depression and anxiety, in mice. Place and Duration of Study: Sample: Department of Pharmacology and Department of Urology, Sakarya University, Animal Research Center, between June 2019 and September 2020. Methodology: Here, we examined the effects of terazosin (0.5, 1, 2 mg/kg), silodosin silodosin (1, 3, 10 mg/kg) and alfuzosin (3, 6 and 9 mg/kg) on depression and anxiety by using forced swimming test and elevated plus maze test, respectively, in mice (n:96). Additionally, the locomotor activity was evaluated by open field test. Results: All doses of terazosin, alfuzosin and silodosin significantly increased immobility time, compared to saline group. Silodosin and alfuzosin prolonged the time spent in open arms but terazosin decreased the time spent in open arms compared to saline group. Terazosin, silodosin (1 and 3 mg/kg) and alfuzosin (3 and 6 mg/kg) did not have any effect on the number of entries into the open arms while silodosin (10 mg/kg) and alfuzosin (9 mg/kg) increased the number of entries into open arms. Conclusion: We found that silodosin and alfuzosin had antidepressant and anxiolytic-like effects, while terazosin had depressant and anxiogenic effects. Patients with BPH who need antidepressant and anxiolytic treatment can be treated with a single drug instead of multiple medications.
- 15 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 78-87
Effects of Terazosin, Silodosin and Alfuzosin on Depression and Anxiety in Mice
Aims: Benign prostatic hyperplasia (BPH) is common urological disease, is characterized by lower urinary tract syndrome, usually associated with sexual dysfunctions. The aim of present study is to investigate the effects of terazosin, silodosin and alfuzosin which are the main treatment options for BPH on depression and anxiety to understand whether these drugs may be effective in BPH caused mood disorders. Study Design: All the drugs were given intraperitoneally (i.p.) in a volume of 0.1 ml per 10 g body weight of mice. Drugs were given 30 min before the experiment. We investigated the effects of terazosin, silodosin and alfuzosin on depression and anxiety, in mice. Place and Duration of Study: Sample: Department of Pharmacology and Department of Urology, Sakarya University, Animal Research Center, between June 2019 and September 2020. Methodology: Here, we examined the effects of terazosin (0.5, 1, 2 mg/kg), silodosin silodosin (1, 3, 10 mg/kg) and alfuzosin (3, 6 and 9 mg/kg) on depression and anxiety by using forced swimming test and elevated plus maze test, respectively, in mice (n:96). Additionally, the locomotor activity was evaluated by open field test. Results: All doses of terazosin, alfuzosin and silodosin significantly increased immobility time, compared to saline group. Silodosin and alfuzosin prolonged the time spent in open arms but terazosin decreased the time spent in open arms compared to saline group. Terazosin, silodosin (1 and 3 mg/kg) and alfuzosin (3 and 6 mg/kg) did not have any effect on the number of entries into the open arms while silodosin (10 mg/kg) and alfuzosin (9 mg/kg) increased the number of entries into open arms. Conclusion: We found that silodosin and alfuzosin had antidepressant and anxiolytic-like effects, while terazosin had depressant and anxiogenic effects. Patients with BPH who need antidepressant and anxiolytic treatment can be treated with a single drug instead of multiple medications.
- Open Access
- 9 December 2021
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Siyamemazin, Blonanserin ve Nemonaprid'in Farelerde Vas Deferens Kasılmaları Üzerine Etkileri
Öz: Amaçlar: Antipsikotik ilaçların yaygın olarak cinsel işlev bozukluğu ile ilişkili olduğu bilinmektedir. Ancak atipik antipsikotik ilaçların bu etkilerine ilişkin çalışmalar oldukça sınırlıdır. Bu çalışmanın amacı, fare vas deferensinin serotonin (5-HT), noradrenalin (NA), adenozin trifosfat (ATP) ve potasyum klorür (KCl) ile indüklenen kasılmaları üzerine siyamemazin, blonanserin ve nemonaprid'in etkilerini araştırmaktır. Gereç ve Yöntemler: Bu çalışmada erkek kendi içinde yetiştirilmiş fareler kullanılmıştır. Fareler rastgele deney gruplarına (n=7) şu şekilde ayrıldı: salin; siyamemazin 0,25 mg/kg; siyamemazin 0,50 mg/kg; blonanserin 0,5 mg / kg; blonanserin 1 mg/kg; nemonaprid 0,5 mg / kg; nemonaprid 1 mg / kg. Farelere, 21 gün boyunca ilaçlar intraperitoneal olarak uygulandı. 21 gün boyunca %0.9 salin alan fareler kontrol grubunu oluşturdu. 21 günlük tedaviden sonra, ilaçların etkileri, fare vas deferensinin epididimal ve prostatik bölümlerine 5-HT, NA, ATP ve KCl'nin neden olduğu kasılma tepkileri araştırıldı. Bulgular: Siyamemazin ve blonanserin ile tedavi edilen fare vas deferenslerinin hem epididimal ve hem de prostatik kısımlarında, 5-HT ile indüklenen kasılma tepkileri anlamlı bir şekilde arttı. Ayrıca, siyamemazin, blonanserin ve nemonaprid uygulanan fare vas deferenslerinin prostatik ve epididimal kısımları; NA, ATP, KCl ile indüklenen kasılmaları önemli ölçüde değiştirmedi. Sonuçlar: Bu sonuçlar, vas deferens'in serotonin kaynaklı kasılmalarının, kronik siyamemazin ve blonanserin tedavilerinden etkilendiğini, ancak nemonapridden etkilenmediğini gösterdi. Ancak bu ilaçların NA, ATP ve KCl ile indüklenen kasılmalar üzerinde önemli bir etkisi yoktu. Serotonerjik reseptörler, kronik ciamemazin ve blonanserin tedavisi gören farelerde vas deferens kasılmalarındaki değişikliklere katkıda bulunabilir. Bu nedenle, sonuçlarımız, siyamemazin ve blonanserin'in neden olduğu cinsel işlev bozukluğunun nedenlerinden birini açıklayabilir. Objectives: Antipsychotic drugs are known to be commonly associated with sexual dysfunction. However, studies on the effects of atypical antipsychotic drugs are very limited. The aim of this study to investigate the effects of cyamemazine, blonanserin and nemonapride on serotonin (5-HT), noradrenaline (NA), adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in mice. Material and Methods: Male inbred mice were used in this study. The mice were randomly divided into experimental groups (n=7) as follows: saline; cyamemazine 0,25 mg / kg; cyamemazine 0,50 mg / kg; blonanserin 0,5 mg / kg; blonanserin 1 mg / kg; nemonapride 0,5 mg / kg; nemonapride 1 mg / kg. Mice were treated by ip injection of drugs for 21 days. Mice receiving only the vehicle (0.9% saline, i.p.) during 21days served as control group. After 21 days of treatment, the effects of drugs were investigated on 5-HT, NA, ATP and KCl-induced contractile responses in the epididymal and prostatic portions of mice vas deferens strips. Results: 5-HT-induced contractile responses were significantly increased in both the epididymal and prostatic portions of mice vas deferens in cyamemazine and blonanserin but not nemonapride-treated groups. In addition, NA, ATP and KCl-induced contractions did not significantly alter contractile responses of prostatic and epididymal portions of mice vas deferens in cyamemazine, blonanserin, and nemonapride-treated groups. Conclusions: These results showed that serotonin-induced contractions of vas deferens were affected by the chronic treatments of ciamemazine and blonanserin but not nemonapride. All drugs had no significant effect on NA, ATP and KCl-induced contractions of mice vas deferens. Serotonergic receptors may contribute to changes in vas deferens contractions in mice with chronic treatment of ciamemazine and blonanserin. Thus, our results may explain one of the causes of sexual dysfunction of ciamemazine and blonanserin.
- 9 December 2021
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Open AccessSiyamemazin, Blonanserin ve Nemonaprid'in Farelerde Vas Deferens Kasılmaları Üzerine Etkileri
Öz: Amaçlar: Antipsikotik ilaçların yaygın olarak cinsel işlev bozukluğu ile ilişkili olduğu bilinmektedir. Ancak atipik antipsikotik ilaçların bu etkilerine ilişkin çalışmalar oldukça sınırlıdır. Bu çalışmanın amacı, fare vas deferensinin serotonin (5-HT), noradrenalin (NA), adenozin trifosfat (ATP) ve potasyum klorür (KCl) ile indüklenen kasılmaları üzerine siyamemazin, blonanserin ve nemonaprid'in etkilerini araştırmaktır. Gereç ve Yöntemler: Bu çalışmada erkek kendi içinde yetiştirilmiş fareler kullanılmıştır. Fareler rastgele deney gruplarına (n=7) şu şekilde ayrıldı: salin; siyamemazin 0,25 mg/kg; siyamemazin 0,50 mg/kg; blonanserin 0,5 mg / kg; blonanserin 1 mg/kg; nemonaprid 0,5 mg / kg; nemonaprid 1 mg / kg. Farelere, 21 gün boyunca ilaçlar intraperitoneal olarak uygulandı. 21 gün boyunca %0.9 salin alan fareler kontrol grubunu oluşturdu. 21 günlük tedaviden sonra, ilaçların etkileri, fare vas deferensinin epididimal ve prostatik bölümlerine 5-HT, NA, ATP ve KCl'nin neden olduğu kasılma tepkileri araştırıldı. Bulgular: Siyamemazin ve blonanserin ile tedavi edilen fare vas deferenslerinin hem epididimal ve hem de prostatik kısımlarında, 5-HT ile indüklenen kasılma tepkileri anlamlı bir şekilde arttı. Ayrıca, siyamemazin, blonanserin ve nemonaprid uygulanan fare vas deferenslerinin prostatik ve epididimal kısımları; NA, ATP, KCl ile indüklenen kasılmaları önemli ölçüde değiştirmedi. Sonuçlar: Bu sonuçlar, vas deferens'in serotonin kaynaklı kasılmalarının, kronik siyamemazin ve blonanserin tedavilerinden etkilendiğini, ancak nemonapridden etkilenmediğini gösterdi. Ancak bu ilaçların NA, ATP ve KCl ile indüklenen kasılmalar üzerinde önemli bir etkisi yoktu. Serotonerjik reseptörler, kronik ciamemazin ve blonanserin tedavisi gören farelerde vas deferens kasılmalarındaki değişikliklere katkıda bulunabilir. Bu nedenle, sonuçlarımız, siyamemazin ve blonanserin'in neden olduğu cinsel işlev bozukluğunun nedenlerinden birini açıklayabilir. Objectives: Antipsychotic drugs are known to be commonly associated with sexual dysfunction. However, studies on the effects of atypical antipsychotic drugs are very limited. The aim of this study to investigate the effects of cyamemazine, blonanserin and nemonapride on serotonin (5-HT), noradrenaline (NA), adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in mice. Material and Methods: Male inbred mice were used in this study. The mice were randomly divided into experimental groups (n=7) as follows: saline; cyamemazine 0,25 mg / kg; cyamemazine 0,50 mg / kg; blonanserin 0,5 mg / kg; blonanserin 1 mg / kg; nemonapride 0,5 mg / kg; nemonapride 1 mg / kg. Mice were treated by ip injection of drugs for 21 days. Mice receiving only the vehicle (0.9% saline, i.p.) during 21days served as control group. After 21 days of treatment, the effects of drugs were investigated on 5-HT, NA, ATP and KCl-induced contractile responses in the epididymal and prostatic portions of mice vas deferens strips. Results: 5-HT-induced contractile responses were significantly increased in both the epididymal and prostatic portions of mice vas deferens in cyamemazine and blonanserin but not nemonapride-treated groups. In addition, NA, ATP and KCl-induced contractions did not significantly alter contractile responses of prostatic and epididymal portions of mice vas deferens in cyamemazine, blonanserin, and nemonapride-treated groups. Conclusions: These results showed that serotonin-induced contractions of vas deferens were affected by the chronic treatments of ciamemazine and blonanserin but not nemonapride. All drugs had no significant effect on NA, ATP and KCl-induced contractions of mice vas deferens. Serotonergic receptors may contribute to changes in vas deferens contractions in mice with chronic treatment of ciamemazine and blonanserin. Thus, our results may explain one of the causes of sexual dysfunction of ciamemazine and blonanserin.
- Open Access
- 1 December 2021
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 6 (4) , 500-507
Chronic Effects of Ziprasidone, Aripiprazole, Blonanserin, Cyamemazine, and Nemonapride on Mice Isolated Detrusor Smooth Muscle
Objective: Ziprasidone, aripiprazole, blonanserin, cyamemazine, and nemonapride are atypical antipsychotic drugs used for the treatment of schizophrenia. This study aimed to identify the effects of these atypical antipsychotic drugs in mice isolated bladder using the organ bath systemMaterials and Methods: The mice were injected intraperitoneally with drugs for 21 days. The effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips. The detrusor strips were stimulated with KCl, then tissues were washed for a further 30 min and precontracted with a submaximal concentration of carbachol. After the contraction reached a plateau, cumulative concentration-response curves to isoproterenol were obtained.Results: We showed that carbachol-induced contractions dose-dependently relaxed by isoproterenol in mice detrusor strips obtained from ziprasidone, aripiprazole, blonanserin, and cyamemazine but not nemonapride treated group. However, none of the drug treatments had any effect KCl responses of mice's bladder.Conclusion: Ziprasidone, aripiprazole, blonanserin, and cyamemazine but not nemonapride increased the isoproterenol-induced relaxations of the detrusor smooth muscle indicates that it can increase the bladder capacity. We demonstrate that four drugs may represent a potential treatment for overactive bladder. They might be clinically useful for the treatment of overactive bladder in patients that should use antipsychotics.
- 1 December 2021
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 6 (4) , 500-507
Open AccessChronic Effects of Ziprasidone, Aripiprazole, Blonanserin, Cyamemazine, and Nemonapride on Mice Isolated Detrusor Smooth Muscle
Objective: Ziprasidone, aripiprazole, blonanserin, cyamemazine, and nemonapride are atypical antipsychotic drugs used for the treatment of schizophrenia. This study aimed to identify the effects of these atypical antipsychotic drugs in mice isolated bladder using the organ bath systemMaterials and Methods: The mice were injected intraperitoneally with drugs for 21 days. The effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips. The detrusor strips were stimulated with KCl, then tissues were washed for a further 30 min and precontracted with a submaximal concentration of carbachol. After the contraction reached a plateau, cumulative concentration-response curves to isoproterenol were obtained.Results: We showed that carbachol-induced contractions dose-dependently relaxed by isoproterenol in mice detrusor strips obtained from ziprasidone, aripiprazole, blonanserin, and cyamemazine but not nemonapride treated group. However, none of the drug treatments had any effect KCl responses of mice's bladder.Conclusion: Ziprasidone, aripiprazole, blonanserin, and cyamemazine but not nemonapride increased the isoproterenol-induced relaxations of the detrusor smooth muscle indicates that it can increase the bladder capacity. We demonstrate that four drugs may represent a potential treatment for overactive bladder. They might be clinically useful for the treatment of overactive bladder in patients that should use antipsychotics.